IRIX
IRIDEX CorporationNASDAQHealthcare$0.98+1.66%ClosedMarket Cap: $16.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.48
P/S
0.33
EV/EBITDA
-15.27
DCF Value
$-6.48
FCF Yield
-12.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
36.7%
Operating Margin
-4.9%
Net Margin
-8.4%
ROE
-107.5%
ROA
-15.2%
ROIC
-15.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $14.7M | 38.3% | $-15.0K | $-184.0K | $-0.01 | — |
| FY 2025 | $52.7M | 36.7% | $-2.6M | $-4.4M | $-0.26 | — |
| Q3 2025 | $12.5M | 32.1% | $-1.4M | $-1.6M | $-0.09 | — |
| Q2 2025 | $13.6M | 33.9% | $-940.0K | $-994.0K | $-0.06 | — |
| Q1 2025 | $11.9M | 42.5% | $-205.0K | $-1.7M | $-0.10 | — |
| Q4 2024 | $12.7M | 44.0% | $-502.0K | $-834.0K | $-0.05 | — |
| FY 2024 | $48.7M | 40.1% | $-8.3M | $-8.9M | $-0.54 | — |
| Q3 2024 | $11.6M | 37.3% | $-1.9M | $-1.9M | $-0.12 | — |
| Q2 2024 | $12.6M | 40.7% | $-2.6M | $-2.7M | $-0.16 | — |
| Q1 2024 | $11.8M | 37.2% | $-3.3M | $-3.5M | $-0.21 | — |
| Q4 2023 | $12.5M | 38.6% | $-3.1M | $-3.0M | $-0.18 | — |
| FY 2023 | $51.9M | 42.0% | $-10.0M | $-9.6M | $-0.59 | — |